Guangdong True Health Medical Technology (HKG:2697) entered into a strategic cooperation framework agreement with General Technology Liaoning Pharmaceutical to develop minimally invasive oncology diagnosis and treatment services in China's three northeastern provinces.
The cooperation, entered on Aug. 22, will cover specialty service development, medical equipment technical services and operating leases, according to a Tuesday Hong Kong bourse filing.